Invention Grant
- Patent Title: Quinazolin-oxime derivatives as Hsp90 inhibitors
- Patent Title (中): 喹唑啉肟衍生物作为Hsp90抑制剂
-
Application No.: US12599116Application Date: 2008-05-15
-
Publication No.: US08592430B2Publication Date: 2013-11-26
- Inventor: Stephen Martin Courtney , Mark Whittaker , Owen Clifford Mather , Christopher John Yarnold , Oliver Robin Barker , Christian Aldo Georges Napoleon Montalbetti , Thomas Hesterkamp , Mihaly Daniel Gardiner
- Applicant: Stephen Martin Courtney , Mark Whittaker , Owen Clifford Mather , Christopher John Yarnold , Oliver Robin Barker , Christian Aldo Georges Napoleon Montalbetti , Thomas Hesterkamp , Mihaly Daniel Gardiner
- Applicant Address: IT Milan
- Assignee: DAC SLR
- Current Assignee: DAC SLR
- Current Assignee Address: IT Milan
- Agency: Cooper & Dunham LLP
- Agent Gary J. Gershik
- Priority: GB0709534.2 20070517
- International Application: PCT/IT2008/000326 WO 20080515
- International Announcement: WO2008/142720 WO 20081127
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/519 ; C07D239/84
Abstract:
Compounds of general formula (I); or a stereoisomers, tautomers, pharmaceutically acceptable salts, or prodrugs thereof, wherein R1, R2, R3, R4, R5, R6, R8 and R9 are as defined herein, are useful for the treatment of diseases and conditions which are mediated by excessive or inappropriate Hsp90 activity such as cancers, viral infection and inflammatory diseases or conditions.
Public/Granted literature
- US20110118258A1 QUINAZOLIN-OXIME DERIVATIVES AS HSP90 INHIBITORS Public/Granted day:2011-05-19
Information query
IPC分类:
